# CapsoVision, Inc: filings

CV · Nasdaq · CIK 1378325 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cv.md) · [Financials](/companies/cv/financials.md) · [Filings](/companies/cv/filings.md) · [Insiders](/companies/cv/insiders.md)

## Reports and events: 30 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 41, 8-K 19, 3 15, D 13, 4/A 5, 10-Q 4, CORRESP 4, D/A 4, SCHEDULE 13G 4, EFFECT 3, S-1/A 3, SCHEDULE 13G/A 3, UPLOAD 3, 424B5 2, DRS 2, DRSLTR 2, S-1 2, 10-K 1, 424B3 1, 424B4 1, 8-A12B 1, CERT 1, DEF 14A 1, DRS/A 1, FWP 1, S-3 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 11:03 ET | [8-K](/filings/0001378325-26-000045.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000045 |
| 2026-09-18 | 16:08 ET | [8-K](/filings/0001378325-26-000043.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001378325-26-000043 |
| 2026-08-18 | 17:50 ET | [8-K](/filings/0001378325-26-000039.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000039 |
| 2026-08-13 | 16:35 ET | [10-Q](/filings/0001378325-26-000036.md) | Quarterly report, period 2026-06-30 | 0001378325-26-000036 |
| 2026-08-13 | 16:07 ET | [8-K](/filings/0001378325-26-000035.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000035 |
| 2026-07-02 | 16:10 ET | [8-K](/filings/0001378325-26-000026.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001378325-26-000026 |
| 2026-06-12 | 14:14 ET | [8-K](/filings/0001378325-26-000023.md) | 5.07 Shareholder vote results | 0001378325-26-000023 |
| 2026-05-14 | 16:35 ET | [10-Q](/filings/0001378325-26-000021.md) | Quarterly report, period 2026-03-31 | 0001378325-26-000021 |
| 2026-05-14 | 16:08 ET | [8-K](/filings/0001378325-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000019 |
| 2026-04-28 | 12:39 ET | [DEF 14A](/filings/0001378325-26-000013.md) | Proxy statement, period 2025-12-31 | 0001378325-26-000013 |
| 2026-04-17 | 16:34 ET | [S-1](/filings/0001628280-26-025785.md) | Registration statement | 0001628280-26-025785 |
| 2026-03-26 | 16:44 ET | [10-K](/filings/0001378325-26-000010.md) | Annual report, period 2025-12-31 | 0001378325-26-000010 |
| 2026-03-26 | 16:08 ET | [8-K](/filings/0001378325-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000008 |
| 2026-03-20 | 08:04 ET | [8-K](/filings/0001378325-26-000004.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000004 |
| 2026-03-13 | 16:32 ET | [8-K](/filings/0001378325-26-000002.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001378325-26-000002 |
| 2025-12-29 | 16:10 ET | [8-K](/filings/0001378325-25-000043.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000043 |
| 2025-11-13 | 16:36 ET | [10-Q](/filings/0001378325-25-000040.md) | Quarterly report, period 2025-09-30 | 0001378325-25-000040 |
| 2025-11-13 | 16:07 ET | [8-K](/filings/0001378325-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-25-000039 |
| 2025-11-10 | 16:09 ET | [8-K](/filings/0001378325-25-000031.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000031 |
| 2025-11-03 | 08:01 ET | [8-K](/filings/0001378325-25-000027.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001378325-25-000027 |
| 2025-09-26 | 16:15 ET | [8-K](/filings/0001378325-25-000022.md) | 5.02 Departure or appointment of officers or directors | 0001378325-25-000022 |
| 2025-09-03 | 17:20 ET | [8-K](/filings/0001378325-25-000018.md) | 5.02 Departure or appointment of officers or directors | 0001378325-25-000018 |
| 2025-08-14 | 17:05 ET | [10-Q](/filings/0001378325-25-000010.md) | Quarterly report, period 2025-06-30 | 0001378325-25-000010 |
| 2025-08-14 | 16:23 ET | [8-K](/filings/0001378325-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-25-000008 |
| 2025-07-18 | 16:49 ET | [8-K](/filings/0001378325-25-000002.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000002 |
| 2025-07-03 | 17:03 ET | [8-K](/filings/0001193125-25-155527.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155527 |
| 2025-06-27 | 18:24 ET | [S-1/A](/filings/0001193125-25-149285.md) | Registration statement, amended | 0001193125-25-149285 |
| 2025-06-13 | 17:00 ET | [S-1/A](/filings/0001193125-25-140836.md) | Registration statement, amended | 0001193125-25-140836 |
| 2025-05-30 | 17:11 ET | [S-1/A](/filings/0001193125-25-132293.md) | Registration statement, amended | 0001193125-25-132293 |
| 2025-05-09 | 16:11 ET | [S-1](/filings/0001193125-25-116894.md) | Registration statement | 0001193125-25-116894 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.